DE69834028D1 - Zinkfreie insulinkristalle für die verwendung in medikamenten, die über die lunge verabreicht werden. - Google Patents

Zinkfreie insulinkristalle für die verwendung in medikamenten, die über die lunge verabreicht werden.

Info

Publication number
DE69834028D1
DE69834028D1 DE69834028T DE69834028T DE69834028D1 DE 69834028 D1 DE69834028 D1 DE 69834028D1 DE 69834028 T DE69834028 T DE 69834028T DE 69834028 T DE69834028 T DE 69834028T DE 69834028 D1 DE69834028 D1 DE 69834028D1
Authority
DE
Germany
Prior art keywords
lunge
free insulin
zinc free
insulin crystals
medicaments delivered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834028T
Other languages
English (en)
Other versions
DE69834028T2 (de
Inventor
Svend Havelund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE69834028D1 publication Critical patent/DE69834028D1/de
Application granted granted Critical
Publication of DE69834028T2 publication Critical patent/DE69834028T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
DE69834028T 1997-03-20 1998-03-20 Zinkfreie insulinkristalle für die verwendung in medikamenten, die über die lunge verabreicht werden. Expired - Lifetime DE69834028T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK31797 1997-03-20
DK31797 1997-03-20
PCT/DK1998/000109 WO1998042749A1 (en) 1997-03-20 1998-03-20 Zinc free insulin crystals for use in pulmonary compositions

Publications (2)

Publication Number Publication Date
DE69834028D1 true DE69834028D1 (de) 2006-05-18
DE69834028T2 DE69834028T2 (de) 2006-12-07

Family

ID=8092195

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834028T Expired - Lifetime DE69834028T2 (de) 1997-03-20 1998-03-20 Zinkfreie insulinkristalle für die verwendung in medikamenten, die über die lunge verabreicht werden.

Country Status (17)

Country Link
US (2) US20070093411A1 (de)
EP (2) EP1627642A3 (de)
JP (1) JP3764174B2 (de)
KR (1) KR20000076419A (de)
CN (1) CN1259142A (de)
AT (1) ATE321783T1 (de)
AU (1) AU742591B2 (de)
BR (1) BR9808285A (de)
CA (1) CA2283705A1 (de)
DE (1) DE69834028T2 (de)
ES (1) ES2260832T3 (de)
HU (1) HUP0000547A3 (de)
IL (1) IL131796A0 (de)
NO (1) NO994520L (de)
PL (1) PL335777A1 (de)
RU (1) RU2198181C2 (de)
WO (1) WO1998042749A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE397013T1 (de) 1997-09-05 2008-06-15 Altus Pharmaceuticals Inc Kohlenhydrat-vernetzte glykoproteinkristalle
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
ZA989744B (en) * 1997-10-31 2000-04-26 Lilly Co Eli Method for administering acylated insulin.
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
EP2311436A1 (de) 1998-04-27 2011-04-20 Altus Pharmaceuticals Inc. Stabilisierte Protein-Kristalle, diese enthaltende Formulierungen und ihre Herstellungsverfahren
SG121739A1 (en) * 1998-04-27 2006-05-26 Altus Pharmaceuticals Inc Stabilized protein crystals, formulations containing them and methods of making them
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
AU4450700A (en) * 1999-04-27 2000-11-10 Eli Lilly And Company Insulin crystals for pulmonary administration
GB0011807D0 (en) * 2000-05-16 2000-07-05 Quadrant Holdings Cambridge Formulation for inhalation
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
US7193035B2 (en) 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
DE10250297A1 (de) * 2002-10-29 2004-05-19 Aventis Pharma Deutschland Gmbh Kristalle von Insulinanaloga und Verfahren zu ihrer Herstellung
BRPI0413276B8 (pt) * 2003-08-05 2021-05-25 Novo Nordisk As derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica
AU2005209199B2 (en) 2004-01-16 2008-09-11 Biodel Inc. Sublingual drug delivery device
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
KR100798333B1 (ko) * 2005-08-03 2008-01-28 고려대학교 산학협력단 락토오스 운반체와 혼합건조된 폐 전달용 인슐린미세결정분말
WO2010043566A2 (de) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Kombination von einem insulin und einem glp-1-agonisten
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
BR112012002934B1 (pt) * 2009-08-11 2021-12-21 Biocon Limited Processos cromatográficos e seus compostos purificados
US9707176B2 (en) 2009-11-13 2017-07-18 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist and methionine
ES2855146T3 (es) 2009-11-13 2021-09-23 Sanofi Aventis Deutschland Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PT2750699E (pt) 2011-08-29 2015-11-03 Sanofi Aventis Deutschland Acelerómetro pendular
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
RU2694063C2 (ru) * 2014-07-08 2019-07-09 Эмфастар Фармасьютикалз, Инк. Тонкодисперсный инсулин, тонкодисперсные аналоги инсулина и способы их промышленного получения
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN104761632A (zh) * 2015-04-14 2015-07-08 珠海联邦制药股份有限公司 一种地特胰岛素结晶的制备方法及应用
CN106117345B (zh) * 2015-05-05 2020-11-24 宜昌东阳光长江药业股份有限公司 一种制备甘精胰岛素结晶的方法
JP2018531900A (ja) 2015-08-25 2018-11-01 ノヴォ ノルディスク アー／エス 新規インスリン誘導体及びその医学的使用
JP2018531899A (ja) 2015-08-25 2018-11-01 ノヴォ ノルディスク アー／エス 新規インスリン誘導体及びその医学的使用
CN108026156A (zh) 2015-08-25 2018-05-11 诺和诺德股份有限公司 新型胰岛素衍生物及其医学用途
US10322168B2 (en) 2016-01-07 2019-06-18 Amphastar Pharmaceuticals, Inc. High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
CN106749616B (zh) * 2016-12-19 2021-09-03 华润昂德生物药业有限公司 B30位苏氨酸缺失人胰岛素晶体的制备方法
CN109957001B (zh) * 2017-12-26 2022-11-18 甘李药业股份有限公司 甘赖脯胰岛素结晶的制备方法
PL238016B1 (pl) * 2018-07-06 2021-06-28 Bioton Spolka Akcyjna Krystaliczna, bezcynkowa postać insuliny glargine i sposób jej otrzymywania
CN114787184A (zh) 2019-12-11 2022-07-22 诺和诺德股份有限公司 新型胰岛素类似物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3719655A (en) * 1969-12-05 1973-03-06 Lilly Co Eli Process for the crystallization of the ammonium and alkali metal salts in insulin
DE3327928A1 (de) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
ATE204882T1 (de) * 1993-09-17 2001-09-15 Novo Nordisk As Acyliertes insulin
ES2218543T3 (es) * 1994-03-07 2004-11-16 Nektar Therapeutics Procedimiento y preparacion para la administracion de insulina por via pulmonar.
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
US5597893A (en) * 1994-10-31 1997-01-28 Eli Lilly And Company Preparation of stable insulin analog crystals
US5700904A (en) * 1995-06-07 1997-12-23 Eli Lilly And Company Preparation of an acylated protein powder
US5898067A (en) * 1997-02-07 1999-04-27 Novo Nordisk A/S Crystallization of proteins
US6310038B1 (en) * 1997-03-20 2001-10-30 Novo Nordisk A/S Pulmonary insulin crystals
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität

Also Published As

Publication number Publication date
NO994520D0 (no) 1999-09-17
CA2283705A1 (en) 1998-10-01
US20070292520A1 (en) 2007-12-20
EP1627642A3 (de) 2006-04-19
NO994520L (no) 1999-09-17
AU742591B2 (en) 2002-01-10
AU6612098A (en) 1998-10-20
CN1259142A (zh) 2000-07-05
ATE321783T1 (de) 2006-04-15
HUP0000547A3 (en) 2002-11-28
JP2001506272A (ja) 2001-05-15
EP1005490A1 (de) 2000-06-07
EP1627642A2 (de) 2006-02-22
IL131796A0 (en) 2001-03-19
KR20000076419A (ko) 2000-12-26
JP3764174B2 (ja) 2006-04-05
RU2198181C2 (ru) 2003-02-10
PL335777A1 (en) 2000-05-22
DE69834028T2 (de) 2006-12-07
WO1998042749A1 (en) 1998-10-01
EP1005490B1 (de) 2006-03-29
HUP0000547A2 (hu) 2000-08-28
US20090311326A9 (en) 2009-12-17
BR9808285A (pt) 2000-05-16
ES2260832T3 (es) 2006-11-01
US20070093411A1 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
DE69834028D1 (de) Zinkfreie insulinkristalle für die verwendung in medikamenten, die über die lunge verabreicht werden.
DE59510597D1 (de) 3-aryl-tetronsäure-derivate, deren herstellung und deren verwendung als schädlingsbekämpfungsmittel
ATE106389T1 (de) Neue benzoesäure- und phenylessigsäurederivate, ihre herstellung und verwendung als heilmittel.
DE3669315D1 (de) Phenoxyalkylaminopyrimidinderivate, deren herstellung und diese enthaltende insektizide und akarizide zusammensetzungen.
AU1650388A (en) Tetrazole intermediates to antihypertensive compounds
HUP0103504A2 (hu) Indeno-, nafto- és benzociklohepta-dihidrotiazol-származékok, eljárás előállításukra és alkalmazásuk anorektikus gyógyszerekként
DE3581613D1 (de) Triazolderivate, deren herstellung und verwendung als schaedlingsbekaempfungsmittel.
DE58907885D1 (de) Benzimidazol-2-carbonsäureanilide, ihre Verwendung als Lichtschutzmittel für organisches Material und mit diesen Aniliden stabilisiertes organisches Material.
CA2262566A1 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
EP0354185A3 (de) Piperidin-Triazin-Verbindungen und ihre Verwendung als Stabilisatoren für organische Materialien
DE3765682D1 (de) Thiolactam-n-essigsaeure-derivate, ihre herstellung und verwendung.
DE3778924D1 (de) Pyridazinon-derivate, deren herstellung und insektizide, akarizide, nematizide, fungizide zusammenstellungen.
IT1237129B (it) Composti piperidin-triazinici atti all'impiego come stabilizzanti per materiali organici.
DE3874206D1 (de) 2-(3-4-dihydroxyphenyl)-aethylamine, ihre herstellung und ihre verwendung als arzneimittel.
DE3684334D1 (de) Antibiotika, "chloropolysporine b und c" genannt, ein verfahren zu ihrer herstellung und ihre therapeutische und veterinaere verwendung.
DE3681856D1 (de) Pharmazeutische 2-oxopyrrolidinverbindungen, ihre salze und ihre herstellung.
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.
DE68913498T2 (de) 1,1-dioxo-cephem-4-carbothiolsäure-derivate.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE69010949T2 (de) Heterocyclische Verbindung, ihre Herstellung und Verwendung.
DE3671428D1 (de) Jodsubstituierte cyclopropancarbonsaeurederivate, ihre herstellung, ihre verwendung als parasitizide fuer pflanzen und tiere und sie enthaltende zusammensetzungen.
DE68906049T2 (de) Benzocyclohexan- und benzocycloheptan-derivate und deren salze, verfahren und zwischenprodukte zu deren herstellung, deren verwendung als heilmittel und diese enthaltende zusammensetzungen.
DE3574588D1 (de) N-benzoyl-n'-pyrimidinyloxyphenyl-harnstoffverbindungen, diese enthaltende antitumorische zusammenstellungen und verfahren zu deren herstellung.
DE3886225D1 (de) Pyruvat-Oxidase, ihre Herstellung und Verwendung.
DE3878988D1 (de) 1,2-di(4-isobutylphenyl)aethylen, dessen herstellung und verwendung als zwischenprodukt.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition